Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

S. Yom, Sue; A. Torres‐Saavedra, Pedro; J. Caudell, Jimmy; Waldron, John; L. Gillison, Maura; Xia, Ping; Tam Truong, Minh; S. Kong, Christina; C. Jordan, Richard; M. Subramaniam, Rathan; Yao, Min; H. Chung, Christine; Geiger, J.L.; W. Chan, Jason; O’Sullivan, Brian; Blakaj, Dukagjin; K. Mell, Loren; L. Thorstad, Wade; U. Jones, Christopher; Banerjee, Robyn; Lominska, C.E.; Le, Quynh‐Thu

doi:10.1200/jco.20.03128

Public

Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Published in Journal of Clinical Oncology • Jan 28, 2021

Authors:

Sue S. Yom

Pedro A. Torres‐Saavedra

Jimmy J. Caudell

Abstract

PURPOSE Reducing radiation treatment dose could improve the quality of life (QOL) of patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC). Whether reduced-dose radiation produces disease control and QOL equivalent to standard chemoradiation is not pro...

Subject

Medicine

Radiation therapy

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!